Selective and potent morpholinone inhibitors of the MDM2-p53 interaction

被引：0

作者：

Gonzalez, Ana Z. ^{[1
]}

Eksterowics, John ^{[1
]}

Beck, Hilary P. ^{[1
]}

Canon, Jude ^{[4
]}

Chen, Ada ^{[1
]}

Chow, David ^{[1
]}

Duquette, Jason ^{[1
]}

Fox, Brian M. ^{[1
]}

Fu, Jiasheng ^{[1
]}

Houze, Jonathan ^{[1
]}

Jin, Lixia ^{[1
]}

Li, Yihong ^{[1
]}

Li, Zhihong ^{[1
]}

Lo, Mei-Chu ^{[1
]}

Long, Alexander M. ^{[5
]}

McGee, Lawrence R. ^{[1
]}

McIntosh, Joel ^{[1
]}

Oliner, Jonathan D. ^{[4
]}

Osgood, Tao ^{[4
]}

Rew, Yosup ^{[1
]}

Saiki, Anne Y. ^{[4
]}

Shaffer, Paul ^{[5
]}

Wortman, Sarah ^{[2
]}

Yakowek, Peter ^{[5
]}

Yan, Xuelei ^{[1
]}

Ye, Qiuping ^{[3
]}

Yu, Dongyin ^{[4
]}

Zhao, Xiaoning ^{[1
]}

Zhou, Jing ^{[1
]}

Olson, Steven H. ^{[1
]}

Medina, Julio C. ^{[1
]}

Sun, Daqing ^{[1
]}

机构：

[1] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Pharmaceut, San Francisco, CA 94080 USA

[3] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Dept Therapeut Discovery, Cambridge, MA 02142 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[41] Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2-p53 Inhibitor in Clinical Development
Sun, Daqing
Li, Zhihong
Rew, Yosup
Gribble, Michael
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chen, Xiaoqi
Chow, David
Deignan, Jeffrey
Duquette, Jason
Eksterowicz, John
Fisher, Benjamin
Fox, Brian M.
Fu, Jiasheng
Gonzalez, Ana Z.
De Turiso, Felix Gonzalez-Lopez
Houze, Jonathan B.
Huang, Xin
Jiang, Min
Jin, Lixia
Kayser, Frank
Liu, Jiwen
Lo, Mei-Chu
Long, Alexander M.
Lucas, Brian
McGee, Lawrence R.
McIntosh, Joel
Mihalic, Jeff
Oliner, Jonathan D.
Osgood, Tao
Peterson, Matthew L.
Roveto, Philip
Saiki, Anne Y.
Shaffer, Paul
Toteva, Maria
Wang, Yingcai
Wang, Yu Chung
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Yu, Ming
Zhao, Xiaoning
Zhou, Jing
Zhu, Jiang
Olson, Steven H.
Medina, Julio C.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) : 1454 - 1472
[42] The MDM2-p53 pathway revisited
Subhasree Nag
Jiangjiang Qin
Kalkunte S.Srivenugopal
Minghai Wang
Ruiwen Zhang
TheJournalofBiomedicalResearch, 2013, 27 (04) : 254 - 271
[43] Potent inhibition of human liposarcoma cell growth and survival by novel modulators of the MDM2-p53 interaction
Zhang, Yixiang
Remillard, Stephen P.
Demetri, George D.
Wang, Shaomeng
Debussche, Laurent
Wagner, Andrew J.
CANCER RESEARCH, 2012, 72
[44] Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors
Huang, Wei
Cai, Lulu
Chen, Can
Xie, Xin
Zhao, Qiong
Zhao, Xing
Zhou, Hong-yun
Han, Bo
Peng, Cheng
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (02): : 341 - 351
[45] Rational Design and Binding Mode Duality of MDM2-p53 Inhibitors
de Turiso, Felix Gonzalez-Lopez
Sun, Daqing
Rew, Yosup
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Correll, Tiffany L.
Huang, Xin
Julian, Lisa D.
Kayser, Frank
Lo, Mei-Chu
Long, Alexander M.
McMinn, Dustin
Oliner, Jonathan D.
Osgood, Tao
Powers, Jay P.
Saiki, Anne Y.
Schneider, Steve
Shaffer, Paul
Xiao, Shou-Hua
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (10) : 4053 - 4070
[46] Discovery of Potent and Selective p53-MDM2 Protein-Protein Interaction Inhibitors as Anticancer Drugs
Holzer, Philipp
CHIMIA, 2017, 71 (10) : 716 - 721
[47] Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
Ding, Ke
Lu, Yipin
Nikolovska-Coleska, Zaneta
Wang, Guoping
Qiu, Su
Shangary, Sanjeev
Gao, Wei
Qin, Dongguang
Stuckey, Jeanne
Krajewski, Krzysztof
Roller, Peter P.
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3432 - 3435
[48] Small-molecule MDM2-p53 inhibitors: recent advances
Zhang, Bian
Golding, Bernard T.
Hardcastle, Ian R.
FUTURE MEDICINAL CHEMISTRY, 2015, 7 (05) : 631 - 645
[49] Rational design and binding mode duality of MDM2-p53 inhibitors
de Turiso, Felix Gonzalez-Lopez
Sun, Daqing
Rew, Yosup
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Correll, Tiffanny L.
Huang, Xin
Julian, Lisa D.
Kayser, Frank
Lo, Mei-Chu
Long, Alexander M.
McMinn, Dustin
Oliner, Jonathan D.
Osgood, Tao
Powers, Jay P.
Saiki, Anne Y.
Schneider, Steve
Shaffer, Paul
Xiao, Shou-Hua
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[50] The synthesis and characterization of tetramic acid derivatives as Mdm2-p53 inhibitors
Muszak, Damian
Labuzek, Beata
Brela, Mateusz Z.
Twarda-Clapa, Aleksandra
Czub, Miroslawa
Musielak, Bogdan
Surmiak, Ewa
Holak, Tad A.
JOURNAL OF MOLECULAR STRUCTURE, 2019, 1189 : 161 - 174

← 1 2 3 4 5 →